Scynexis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCYNEXIS, and when can generic versions of SCYNEXIS drugs launch?
SCYNEXIS has one approved drug.
There are five US patents protecting SCYNEXIS drugs.
There are thirty-eight patent family members on SCYNEXIS drugs in twenty-four countries.
Summary for Scynexis
| International Patents: | 38 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Scynexis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scynexis | BREXAFEMME | ibrexafungerp citrate | TABLET;ORAL | 214900-001 | Jun 1, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Scynexis | BREXAFEMME | ibrexafungerp citrate | TABLET;ORAL | 214900-001 | Jun 1, 2021 | RX | Yes | Yes | 10,174,074 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Scynexis | BREXAFEMME | ibrexafungerp citrate | TABLET;ORAL | 214900-001 | Jun 1, 2021 | RX | Yes | Yes | 8,188,085 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Scynexis | BREXAFEMME | ibrexafungerp citrate | TABLET;ORAL | 214900-001 | Jun 1, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scynexis Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 3661503 | ⤷ Try a Trial |
| Lithuania | 3247711 | ⤷ Try a Trial |
| Portugal | 3247711 | ⤷ Try a Trial |
| Hong Kong | 1247196 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
